BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shojaie L, Iorga A, Dara L. Cell Death in Liver Diseases: A Review. Int J Mol Sci 2020;21:E9682. [PMID: 33353156 DOI: 10.3390/ijms21249682] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Knorr J, Wree A, Feldstein AE. Pyroptosis in Steatohepatitis and Liver Diseases. J Mol Biol 2021;:167271. [PMID: 34592216 DOI: 10.1016/j.jmb.2021.167271] [Reference Citation Analysis]
2 Qu W, Ma T, Cai J, Zhang X, Zhang P, She Z, Wan F, Li H. Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies. Front Med (Lausanne) 2021;8:761538. [PMID: 34746195 DOI: 10.3389/fmed.2021.761538] [Reference Citation Analysis]
3 Zhang H, Zhou L, Zhou Y, Wang L, Jiang W, Liu L, Yue S, Zheng P, Liu H. Intermittent hypoxia aggravates non-alcoholic fatty liver disease via RIPK3-dependent necroptosis-modulated Nrf2/NFκB signaling pathway. Life Sci 2021;285:119963. [PMID: 34536498 DOI: 10.1016/j.lfs.2021.119963] [Reference Citation Analysis]
4 Lu D, Xia Q, Yang Z, Gao S, Sun S, Luo X, Li Z, Zhang X, Han S, Li X, Cao M. ENO3 promoted the progression of NASH by negatively regulating ferroptosis via elevation of GPX4 expression and lipid accumulation. Ann Transl Med 2021;9:661. [PMID: 33987359 DOI: 10.21037/atm-21-471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu B, He R, Zhang L, Hao B, Jiang W, Wang W, Geng Q. Inflammatory Caspases Drive Pyroptosis in Acute Lung Injury. Front Pharmacol 2021;12:631256. [PMID: 33613295 DOI: 10.3389/fphar.2021.631256] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Shih HJ, Chang CY, Chiang M, Le VL, Hsu HJ, Huang CJ. Simultaneous Inhibition of Three Major Cytokines and Its Therapeutic Effects: A Peptide-Based Novel Therapy against Endotoxemia in Mice. J Pers Med 2021;11:436. [PMID: 34065201 DOI: 10.3390/jpm11050436] [Reference Citation Analysis]
7 Estévez-Vázquez O, Benedé-Ubieto R, Guo F, Gómez-Santos B, Aspichueta P, Reissing J, Bruns T, Sanz-García C, Sydor S, Bechmann LP, Maranillo E, Sañudo JR, Vázquez MT, Lamas-Paz A, Morán L, Mazariegos MS, Ciudin A, Pericàs JM, Peligros MI, Vaquero J, Martínez-Naves E, Liedtke C, Regueiro JR, Trautwein C, Bañares R, Cubero FJ, Nevzorova YA. Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD). Biomedicines 2021;9:1289. [PMID: 34680405 DOI: 10.3390/biomedicines9101289] [Reference Citation Analysis]
8 Kim JY, Jang HJ, Leem J, Kim GM. Protective Effects of Bee Venom-Derived Phospholipase A2 against Cholestatic Liver Disease in Mice. Biomedicines 2021;9:992. [PMID: 34440196 DOI: 10.3390/biomedicines9080992] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xu C, Liu Z, Xiao J. Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease. Int J Mol Sci 2021;22:12403. [PMID: 34830285 DOI: 10.3390/ijms222212403] [Reference Citation Analysis]
10 Akin AT, Öztürk E, Kaymak E, Karabulut D, Yakan B. Therapeutic effects of thymoquinone in doxorubicin-induced hepatotoxicity via oxidative stress, inflammation and apoptosis. Anat Histol Embryol 2021;50:908-17. [PMID: 34494664 DOI: 10.1111/ahe.12735] [Reference Citation Analysis]
11 Hajduch E, Lachkar F, Ferré P, Foufelle F. Roles of Ceramides in Non-Alcoholic Fatty Liver Disease. J Clin Med 2021;10:792. [PMID: 33669443 DOI: 10.3390/jcm10040792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kim JY, Choi Y, Leem J, Song JE. Heme Oxygenase-1 Induction by Cobalt Protoporphyrin Ameliorates Cholestatic Liver Disease in a Xenobiotic-Induced Murine Model. Int J Mol Sci 2021;22:8253. [PMID: 34361019 DOI: 10.3390/ijms22158253] [Reference Citation Analysis]
13 Luo MY, Su JH, Gong SX, Liang N, Huang WQ, Chen W, Wang AP, Tian Y. Ferroptosis: New Dawn for Overcoming the Cardio-Cerebrovascular Diseases. Front Cell Dev Biol 2021;9:733908. [PMID: 34858973 DOI: 10.3389/fcell.2021.733908] [Reference Citation Analysis]
14 Higuchi A, Wakai E, Tada T, Koiwa J, Adachi Y, Shiromizu T, Goto H, Tanaka T, Nishimura Y. Generation of a Transgenic Zebrafish Line for In Vivo Assessment of Hepatic Apoptosis. Pharmaceuticals (Basel) 2021;14:1117. [PMID: 34832899 DOI: 10.3390/ph14111117] [Reference Citation Analysis]
15 Fu XW, Song CQ. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:748039. [PMID: 34820376 DOI: 10.3389/fcell.2021.748039] [Reference Citation Analysis]
16 El-Aarag B, Attia A, Zahran M, Younes A, Tousson E. New phthalimide analog ameliorates CCl4 induced hepatic injury in mice via reducing ROS formation, inflammation, and apoptosis. Saudi J Biol Sci 2021;28:6384-95. [PMID: 34764756 DOI: 10.1016/j.sjbs.2021.07.014] [Reference Citation Analysis]
17 Gallego-Durán R, Montero-Vallejo R, Maya-Miles D, Lucena A, Martin F, Ampuero J, Romero-Gómez M. Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases. Front Immunol 2021;12:667354. [PMID: 34899679 DOI: 10.3389/fimmu.2021.667354] [Reference Citation Analysis]
18 Lis-López L, Bauset C, Seco-Cervera M, Cosín-Roger J. Is the Macrophage Phenotype Determinant for Fibrosis Development? Biomedicines 2021;9:1747. [PMID: 34944564 DOI: 10.3390/biomedicines9121747] [Reference Citation Analysis]
19 Hameed H, Farooq M, Piquet-Pellorce C, Hamon A, Samson M, Le Seyec J. Questioning the RIPK1 kinase activity involvement in acetaminophen-induced hepatotoxicity in mouse. Free Radic Biol Med 2022;178:243-5. [PMID: 34879229 DOI: 10.1016/j.freeradbiomed.2021.11.042] [Reference Citation Analysis]
20 Chen S, Zhu JY, Zang X, Zhai YZ. The Emerging Role of Ferroptosis in Liver Diseases. Front Cell Dev Biol 2021;9:801365. [PMID: 34970553 DOI: 10.3389/fcell.2021.801365] [Reference Citation Analysis]
21 Mohammed S, Thadathil N, Selvarani R, Nicklas EH, Wang D, Miller BF, Richardson A, Deepa SS. Necroptosis contributes to chronic inflammation and fibrosis in aging liver. Aging Cell 2021;:e13512. [PMID: 34761505 DOI: 10.1111/acel.13512] [Reference Citation Analysis]
22 Huang L, Liu J, Bie C, Liu H, Ji Y, Chen D, Zhu M, Kuang W. Advances in cell death - related signaling pathways in acute-on-chronic liver failure. Clin Res Hepatol Gastroenterol 2021;:101783. [PMID: 34339873 DOI: 10.1016/j.clinre.2021.101783] [Reference Citation Analysis]
23 Shojaie L, Ali M, Iorga A, Dara L. Mechanisms of immune checkpoint inhibitor-mediated liver injury. Acta Pharmaceutica Sinica B 2021;11:3727-39. [DOI: 10.1016/j.apsb.2021.10.003] [Reference Citation Analysis]